675 articles in this topic
ORBITA-FIRE reveals personalized physiological angina thresholds are dramatically lower than the universal FFR/RFR values used to guide stent decisions.
Leading cardiologists respond to reader questions on blood thinner use following AF ablation, refining clinical guidance.
Scientists identify GPRASP1 as a key guardian of pulmonary vascular health, opening a potential drug target for PH-HFpEF.
A specific CD40 signaling branch boosts macrophage cleanup of dead cells after MI, improving cardiac recovery in mice.
A new review examines how drugs that clear senescent cells could transform treatment of age-related cardiovascular disease.
A new review reveals how sirtuin enzymes regulate cardiac fibrosis and why targeting them could reshape heart failure treatment.
A JAMA Cardiology editorial examines how AI-powered ECG tools perform in high-risk, underserved populations where traditional diagnostics fall short.
UC San Diego scientists developed an injectable hydrogel that travels the bloodstream to reduce inflammation and regenerate damaged heart tissue.
Chronic gut inflammation in IBD drives cardiovascular disease through dysbiosis, nutrient deficits, and systemic inflammation — often without traditional warning signs.
Peter Attia answers listener questions on cardiovascular risk, metabolic health, minimum-dose strength training, dementia prevention, and NAD supplements.
New JAMA research suggests ApoB may outperform standard lipid panels for detecting CVD risk in younger populations.
A Cochrane review finds only one small RCT on surgical timing for cardiac surgery, with afternoon starts linked to lower troponin release.
